Group A Streptococcus (GAS) comes exclusively from other humans. Unlike many bacterial infections that originate in animals, contaminated food, or environmental sources, this bacterium has adapted over thousands of years to live in and spread between people. It has no animal reservoir and no significant environmental source. Every case traces back to another person, whether that person was visibly sick or carrying the bacteria without symptoms.
Humans Are the Only Natural Host
GAS lives on specific body sites in humans: the throat, skin, and occasionally the vaginal and anal areas. It can reside at these sites without causing any illness, a state known as asymptomatic carriage. Among school-age children, roughly 10% to 15% carry the bacteria in their throats at any given time with no sore throat or fever. In broader surveys of healthy, symptom-free children, carriage rates range from about 2% to 5%, though school-based studies have found rates as high as 40% depending on how carriage is defined and measured. Adults carry GAS less often, but they can still harbor and transmit it.
This means the bacteria doesn’t “come from” a contaminated lake, a pet, or a piece of undercooked food. It circulates silently through communities, passed between people who may not realize they’re carrying it. While other streptococcal species can jump between animals and humans (species found in dogs, horses, fish, and pigs), GAS itself is strictly human-adapted.
How GAS Spreads Between People
The primary route is respiratory droplets. Coughing, sneezing, and even talking can release tiny droplets containing the bacteria, which another person inhales or catches on their hands. Direct contact with saliva, nasal secretions, or wound discharge from an infected person is another common pathway, which is why GAS spreads readily in close-contact settings like schools, households, and daycare centers.
Surfaces play a smaller role, but they’re not irrelevant. GAS can survive on inanimate objects like glass, toys, and linens for up to a month under laboratory conditions. In real-world settings, this means shared items could theoretically pass the bacteria along during the early phase of an outbreak, though person-to-person contact remains the dominant route by far.
Why It Sticks to Throat and Skin
GAS doesn’t just land on your body and hope for the best. It has a sophisticated set of tools for attaching to human tissue. The process starts with a fatty molecule on the bacterium’s surface that helps it overcome the natural electrical repulsion between bacterial and human cells, creating an initial weak bond. Once close enough, a collection of surface proteins locks the bacterium more firmly in place.
The most important of these is called M protein, which serves double duty. It anchors the bacterium to cells lining the throat and skin, and it also shields the bacterium from your immune system’s first responders. GAS also uses hair-like projections called pili to grip onto tonsils, throat cells, and skin cells. Different strains have different versions of these attachment tools, which partly explains why some strains prefer the throat while others tend to cause skin infections.
Seasonal Patterns of Infection
GAS circulates year-round, but the type of infection it causes shifts with the seasons. Strep throat and scarlet fever peak during winter and spring, roughly December through April in the Northern Hemisphere. This lines up with the time people spend more hours indoors in close quarters, making respiratory droplet transmission easier. Skin infections like impetigo follow the opposite pattern, peaking in summer when exposed skin, minor cuts, and insect bites give the bacteria more opportunities to enter through the skin.
How Strains Evolve and New Waves Emerge
Not all GAS is the same. There are over 200 known types, classified by variations in that M protein on their surface. The dominant types shift over decades, rising and falling in waves across different regions. Two of the most consequential examples illustrate how this happens.
The M1 strain became a global threat through a series of genetic changes between the 1960s and 1980s. It picked up genes from viruses that infect bacteria (called phages), gaining the ability to produce a powerful immune-stimulating toxin and an enzyme that helps it evade white blood cells. A final gene swap around 1983, likely with a different GAS strain, ramped up production of toxins that damage tissue. The result was a strain responsible for a surge in severe, invasive infections worldwide.
A similar story played out with the M89 strain, which acquired a nearly identical toxin-producing gene region from M1 or a related strain and simultaneously lost the ability to make its protective capsule. That trade-off somehow made it more successful, and it spread globally as a new dominant lineage. These shifts happen naturally as strains swap genetic material, and they explain why severe GAS outbreaks can emerge seemingly from nowhere.
Where GAS Enters the Body
For common infections like strep throat, the bacteria enters through the mouth and nose and colonizes the throat lining. For skin infections, it gets in through breaks in the skin: cuts, scrapes, surgical wounds, insect bites, or areas affected by conditions like eczema.
In rare cases, GAS penetrates deeper to cause invasive infections like necrotizing fasciitis (the “flesh-eating” infection), bloodstream infections, or toxic shock syndrome. In most of these cases, the exact entry point is never identified, but it’s presumed to be either skin or the mucous membranes lining the throat, sinuses, or other surfaces. People with open wounds, recent surgery, or weakened immune systems face higher risk of these invasive infections.
A Long History With Humans
GAS has been causing recognizable disease for centuries. A Sicilian physician described what was likely scarlet fever in 1553, calling it “rossalia” and noting patients whose entire bodies appeared “on fire” with a red rash. German physicians documented a similar fatal illness in 1564, particularly deadly in infants, with sore throat, high fever, and a full-body rash. But it wasn’t until 1924 that American bacteriologists Gladys and George Dick proved that the beta-hemolytic bacterium now called Streptococcus pyogenes was the cause, and that a toxin it produced drove the progression to scarlet fever and, later, rheumatic fever. The bacterium’s long, exclusive relationship with humans has shaped its biology at every level, from the surface proteins it uses to grip human cells to the toxins calibrated to manipulate the human immune response.